Introduction
Percutaneous coronary intervention (PCI) is a well-established therapeutic strategy for patients with stable angina pectoris. However, periprocedural myocardial injury (PMI) after PCI is not uncommon and even a small biomarker increase is significantly associated with an adverse short-and long-term outcome. 1 Especially, distal embolization during PCI may deteriorate microvascular perfusion in patients who underwent elective PCI. Numerous efforts have been made to detect high-risk plaque which may cause distal embolization during PCI, using several imaging devices. Of these, frequency-domain optical coherence tomography (FD-OCT) has been recently developed as a high-resolution imaging method to observe culprit lesions more clearly. On the other hand, surface ST-segment change on the electrocardiogram (ECG) reflects myocardial flow and microvascular perfusion after PCI rather than epicardial flow and predicts better myocardial salvage and clinical outcome in acute myocardial infarction patients. 2 However, the sensitivity of surface ECG for detecting ischaemia during elective PCI has been disappointing. 3 Unipolar intracoronary electrocardiogram (IcECG) which represents local epicardial ECG seemed to be more sensitive than surface ECG for detecting local ischaemia and microvascular perfusion during PCI and persistent ST-segment elevation on IcECG reflects impaired microvascular perfusion after PCI. 4 IcECG is a simple, speedy and established method for predicting microvascular perfusion in the catheterization laboratory. 4 This study was undertaken to assess the association between plaque features at culprit lesions assessed by FD-OCT on pre-and post-PCI and microvascular perfusion estimated by IcECG. Furthermore, we investigated whether IcECG could predict future cardiac events after elective PCI.
Methods

Study patient
In total, 460 consecutive patients underwent PCI from January 2014 to March 2016 at Hiroshima University Hospital. Of these, we enrolled 84 patients with stable angina pectoris who underwent elective PCI for a single, native, de novo coronary lesion and performed FD-OCT and IcECG both at baseline and after the procedure in this study. A study flow chart is reported in Figure 1 . All patients had the presence of anginal chest pain and myocardial ischaemia on myocardial perfusion scintigram or the treadmill exercise test or fractional flow reserve. Patient-related exclusion criteria were: (i) acute coronary syndrome; (ii) elevated preprocedural cardiac biomarker; (iii) reduced renal function (Estimated glomerular filtration rate <30 mL/min per 1.73 m 2 ). Lesion-related exclusion criteria were the vessels within a myocardial territory of previous myocardial infarction (MI), the left main trunk, ostium lesions, extremely tight lesions or tortuous vessels where we expected difficulty in advancing soft-tip guidewire or the FD-OCT catheter, severe calcified lesions needed for debulking device, target vessel reference diameter of > _4 mm expected limitation in FD-OCT evaluation and angiographic evidence of coronary dissection or major side branch (>1 mm) occlusion after the procedure. Patients were classified into two groups based on STsegment elevation (ST-E) on IcECG after the procedure; absence of ST-E [ST-E (-) group: n = 53] and presence of ST-E [ST-E (þ) group: n = 31]. Prescription of statins was defined as taking statins at least 7 days before PCI. Multivessel disease was defined as > _50% stenosis in 1 or more Figure 1 Study flow chart. PCI, percutaneous coronary intervention; FD-OCT, frequency-domain optical coherence tomography; IcECG, intracoronary electrocardiogram; ST-E, ST-segment elevation. 
Study protocol
The study protocol was as follows (Figure 2) . First, the baseline IcECG (pre-IcECG) was recorded after positioning the guidewire in the distal part of a target vessel. Second, the baseline FD-OCT (pre-FD-OCT) was performed with or without balloon pre-dilatation (1.5 mm noncompliant balloon, 6 atm). Then coronary stent implantation was performed. The post-procedural FD-OCT (post-FD-OCT) was performed with or without balloon post-dilatation. Finally, the post-procedural IcECG (postIcECG) was recorded after positioning the guidewire in the same part. Blood samples were obtained pre-PCI and at approximately 18 h after PCI to evaluate cardiac biomarkers. A major adverse cardiac event (MACE) was defined as cardiac death, MI, repeat revascularization and/or hospitalization for heart failure. Follow-up angiography was encouraged at 8-10 months after elective PCI or earlier when clinically indicated. Repeat revascularization was identified as any unstaged revascularization after the index procedure. Clinical follow-up was performed for up to 1-year after PCI.
PCI and FD-OCT procedures
All patients were treated by second or third generation drug-eluting stent without any distal protection device according to standard techniques. All patients received dual antiplatelet agents (aspirin 100 mg/day and clopidogrel 75 mg/day, 300 mg loading dose) and statins at least 24 h before the procedure. 7500 IU of unfractionated heparin was administrated before procedure and an additional bolus of heparin was given during PCI, with a target activated clotting time of >250 s every 30 min. No patient received glycoprotein IIb/IIIa receptor inhibitor. In addition, no patient received other intravenous and intracoronary administration except isosorbide dinitrate. All stents were inflated 3 times to the almost nominal inflation pressure using the stent delivery balloon. The first inflation continued until the stent was angiographically fully expanded; the other 2 lasted 15 to 20 s, respectively. FD-OCT system was a commercially available system (C7 System; LightLab Imaging Inc/St Jude Medical, Westford, MA). The FD-OCT catheter (C7 Dragonfly; LightLab Imaging Inc/St Jude Medical, Westford, MA) was advanced to the distal end of the culprit lesion and contrast media was continuously infused into the coronary artery directly from the guiding catheter. Successful PCI was defined as the achievement of <25% residual stenosis, no angiographic stent edge dissection and final thrombolysis in myocardial infarction (TIMI) flow grade 3. After achieving the angiographic end point, no additional PCI was performed.
FD-OCT image analysis
Analysis of the FD-OCT images was performed every 0.2 mm interval by 2 reviewers blinded to the results of the IcECG analysis and clinical data. FD-OCT images were analyzed using validated criteria for thrombus characterization, plaque characterization, ruptured plaque, fibrous cap thickness, incomplete stent apposition, tissue protrusion, edge dissection and intrastent dissection as reported previously. [5] [6] [7] Lipid was semiquantified as the number of involved quadrants on the cross-sectional FD-OCT image. Lipid-rich plaque was defined as plaque with > _2 quadrants. Fibrous cap thickness was defined as the minimum distance from the coronary artery lumen to inner border of lipid pool on the cross-sectional FD-OCT image. The length of lipid pool was measured as consecutive longitudinal length of lipid pool at culprit plaque assessed by FD-OCT. The thin cap fibroatheroma (TCFA) was defined as a plaque with lipid content in > _2 quadrants and the thinnest part of the fibrous cap measuring <65 lm. Culprit plaque was defined as the plaque at the site of minimum lumen diameter.
IcECG recording and analysis
IcECG was recorded both at baseline and after the procedure as reported previously. 3, 4 In brief, a 0.014-inch guidewire (Hi-Torque Balance Middle
Weight-Universal, Abbott Vasclar; Santa Clara, California) was passed distal to the culprit lesion and positioned at the distal epicardial position of a target vessel. Pre-IcECG was recorded just after the guidewire passed. At the end of PCI, the guidewire was placed in the same position as pre-IcECG after all procedure and post-IcECG was recorded. ST-segment elevation on IcECG was measured 20 ms after the end of the QRS or QS complexes to the nearest 0.5 mm. Three consecutive QRS complexes were analyzed and mean ST-segment elevation values were calculated. ST-E (þ) on IcECG was defined as ST-segment elevation > _1 mm from baseline. 3 Representative case of ST-E (þ) on IcECG is shown in Figure 3 . 
Laboratory measurements
Blood samples were collected just before PCI and 18 h after the procedure in the postabsorptive state. Serum troponin-I (TnI) was measured with a commercially available enzyme immunoassay kit (Siemens Healthcare Diagnostics K.K., Tokyo, Japan). The Creatine kinase-MB (CK-MB) activity was measured with the Cica Liquid CK test (Kanto Chemical, Tokyo, Japan).
Statistical analysis
Standard statistical methods were used in this study. 
Results
Clinical, angiographic and procedural results
No PCI related complications occurred and the procedures were successfully completed in all patients. Thirty-one out of 84 patients (36.9%) represented ST-segment elevation on post-IcECG. The baseline characteristics of the study patients are shown in Table 1 . There was no significant difference in all baseline clinical variables except statins at least 7 days before PCI between the two groups. The rate of patients taking statins at least 7 days before PCI was significantly higher in the ST-E (-) group than in the ST-E (þ) group (90.6% vs. 74.2%, P < 0.05). Regarding cardiac biomarkers, no significant difference was observed in CK-MB and TnI level before PCI between the two groups. However, CK-MB and TnI after PCI were significantly higher in the ST-E (þ) group than in the ST-E (-) group (CK-MB; 8.6 ± 3.2 IU/L vs. 13.8 ± 7.5 IU/L, P < 0.001, TnI; 0.14 ng/mL [IQR 0.07 to 0.42] vs. 0.84 ng/mL [IQR 0.29 to 2.07], P < 0.001). In addition, there was no significant difference in other blood chemical parameters between the two groups. Lesion, angiographic and procedural characteristics of the study patients are shown in Table 2 . achieved in all patients. There were no patients with ST-segment elevation on surface ECG after the procedure in the two groups. Five out of 84 lesions (6.0%) were predilated before pre-FD-OCT. Post-dilatation after stent deployment was performed in 66 patients (78.6%) and no significant differences in balloon diameter, dilatation pressure and inflation time were observed between the two groups. No patients had received unexpected additional stent implantation because of angiographic stent edge dissection. There was no significant difference in all lesion, angiographic and procedural variables between the two groups.
Pre-and post-FD-OCT findings FD-OCT findings of the study patients are shown in Table 3 . Thrombus was observed in 7 patients by pre-FD-OCT and these were all red thrombus. Plaque rupture was significantly more frequently found by pre-FD-OCT in the ST-E (þ) group than in the ST-E (-) group (7.5% vs. 35.5%, P = 0.001). Calcification tended to be more frequently found by pre-FD-OCT in the ST-E (þ) group than in the ST-E (-) group, but the differences were not statistically significant (32.1% vs. 51.6%, P = 0.08). Relation between minimum fibrous cap thickness and STsegment elevation on IcECG is shown in Figure 4 . Minimum fibrous cap thickness was significantly thinner in the ST-E (þ) group than in the ST-E (-) group (240 lm [IQR 180 to 310] vs. 100 lm [IQR 60 to 120], P < 0.001). Lipid-rich plaque and TCFA were significantly more frequently found by pre-FD-OCT in the ST-E (þ) group than in the ST-E (-) group (lipid-rich plaque; 75.5% vs. 100%, P < 0.001, TCFA; 0% vs. 25.8%, P < 0.001, respectively). Maximum length of lipid pool was significantly higher in the ST-E (þ) group than in the ST-E (-) group (5.58 ± 2.08 mm vs. 7.51 ± 3.31 mm, P < 0.005). Protrusion and intrastent dissection were significantly more frequently found by post-FD-OCT in the ST-E (þ) group than in the ST-E (-) group (protrusion; 18.9% vs. 56.7%, P < 0.001, intra-stent dissection; 15.1% vs. 50.0%, P < 0.001, respectively). 
Prognosis of ST-segment elevation on IcECG
The median follow-up period was 365 (IQR 207-365) days. The incidence of each constituent factor of MACE at 1-year is shown in Table 4 . One patient in the ST-E (þ) group required revascularization for in-stent restenosis. Four patients in the ST-E (-) group and 5 patients in the ST-E (þ) group required revascularization for remote lesion. The incidence of MACE during 1-year was significantly higher in the ST-E (þ) group than in the ST-E (-) group (5.7% vs. 19.4%, P < 0.05, Figure 5 ).
Intraobserver and interobserver variability
Kappa measure of agreement for intraobserver agreement was 1.00 (P < 0.001) for IcECG, 0.83 (P < 0.001) for TCFA, 0.86 (P < 0.001) for lipid-rich plaque. Interobserver variability for IcECG, TCFA and lipidrich plaque was 0.96 (P < 0.001), 0.80 (P < 0.001) and 0.83 (P < 0.001), respectively. Mean intraobserver difference for the minimum fibrous cap thickness was 9.4 ± 4.1 lm; mean interobserver differences were 10.1 ± 9.0 lm. Mean intraobserver difference for the maximum length of lipid pool was 0.5 ± 0.2 mm; mean interobserver differences were 0.6 ± 0.3 mm.
Discussion
The major finding of the present study was that minimum fibrous cap thickness on pre-FD-OCT was significantly thinner and maximum length of lipid pool on pre-FD-OCT was significantly higher in the ST-E (þ) group than in the ST-E (-) group. In addition, presence of plaque rupture, lipid-rich plaque, TCFA on pre-FD-OCT, protrusion Impaired microvascular perfusion and OCT plaque morphology and intra-stent dissection on post-FD-OCT might predict persistent ST-segment elevation on IcECG in patients who underwent successful elective PCI. Furthermore, the incidence of MACE during 1-year was significantly higher in the ST-E (þ) group than in the ST-E (-) group. To our knowledge, this is the first report to present a relation between plaque features assessed by FD-OCT and microvascular perfusion estimated by IcECG, and prognosis value on IcECG in patients who underwent successful elective PCI. PMI is caused by procedure-related cell necrosis that occurs during PCI. It is diagnosed when an increase of post-procedural cardiac biomarkers is observed, occurring in between 5% and 44% of PCI. 3 PMI have been associated with several factors, which can broadly be categorized as (i) patient-related factors; (ii) lesion-related factors; and (iii) procedure-related factors. 8 Lesion-related factors such as plaque burden, calcification, lesion eccentricity, and thrombus which lead to distal embolization of disrupted plaque contents and residual thrombus, predict PMI. 9 The most common mechanisms of PMI are distal embolization and side branch occlusion. This study was especially focused on lesion-related factors which lead to distal embolization using FD-OCT. Despite the presence of patent epicardial coronary circulation, microvascular perfusion may fail to be acquired in a substantial portion of the perfusion territory of the treated coronary artery because distal atherothrombotic embolization could trigger abnormalities at the level of the microvasculature. 10 Presence of plaque rupture, lipid-rich plaque and TCFA on pre-FD-OCT might predict persistent ST-segment elevation on IcECG in patients who underwent elective PCI, which was consistent with results of previous studies focused on an increase of post-procedural cardiac biomarkers. 11, 12 TCFA is characterized by a large necrotic core and a thin fibrous cap and associated with positive vessel remodeling. 13 Also, TCFA often leads to plaque rupture. 14 The necrotic core component contains fragile tissues such as lipid deposition with foam cells, intramural bleeding, and/or cholesterol crystals. 15 The presence of plaque rupture, lipid-rich plaque and TCFA correlates with more progressive atherosclerosis and vulnerable plaques and results in distal embolization by disrupted plaque contents during PCI. In addition, in the cavity of plaque rupture, there might be residual lipid plaque and organized thrombus. Previous studies have suggested that large plaque volume and lipid-rich plaque at culprit lesions assessed by intravascular ultrasound may be associated with no-reflow phenomenon, resulting in PMI. 16 In this study, maximum length of lipid pool was significantly higher in the ST-E (þ) group than in the ST-E (-) group. It might be useful to evaluate longitudinal extent of lipid pool using FD-OCT to quantify the whole plaque burden accurately. Porto et al. 12 reported that presence of intra-stent thrombus and intra-stent dissection on post-FD-OCT might predict Troponin-T elevation in patients treated with second generation drug-eluting stents . In this study, intra-stent dissection was significantly more frequently found by post-FD-OCT in the ST-E (þ) group than in the ST-E (-) group. However, there was no significant difference in intra-stent thrombus between the two groups. We guess that this discordance was because intra-stent thrombus were observed in only 4 patients in this study and Porto et al included non-ST elevation myocardial infarction patients. Additionally, protrusion was significantly more frequently found by post-FD-OCT in the ST-E (þ) group than in the ST-E (-) group in this study. This finding suggested that thinner fibrous cap and large necrotic cores might be more likely to be destroyed by stent implantation, eventually resulting in impaired microvascular perfusion and tissue protrusion through stent struts reflected this mechanical mechanism. Correspondingly, calcified plaque on pre-FD-OCT might be not easy to be destroyed by stent implantation and introduce distal embolization. Previous studies have reported that ST-segment resolution on IcECG was associated with infarct size assessed by cardiac magnetic resonance imaging (CMR) in MI patients. 17 IcECG seemed to assess local myocardial state in the catheterization laboratory. 4 Larger stent expansion associated with a higher level of post-procedural CK-MB suggests a tradeoff between optimal stent implantation and PMI. 18 Because of monitoring ST-segment changes of IcECG in the catheterization laboratory, evaluation of IcECG might provide useful information on indicating and monitoring of these interventions to optimize stent expansion. To prevent distal embolization during PCI, several trials have been conducted with a variety of embolic distal protection devices. However, The Drug Elution and Distal Protection in ST Elevation Myocardial Infarction (DEDICATION) trial suggested that in primary PCI for ST-segment elevation myocardial infarction, the routine use of distal protection increased the incidence of stent thrombosis and clinically driven target lesion/vessel revascularization because of complexity of use. 19 Therefore, it is necessary to determine patients who will suffer from impaired microvascular perfusion without distal protection devices based on these pre-FD-OCT findings. It was reported that pretreatment with statins decreases the incidence of PMI during PCI. 20 In this study, the rate of patients taking statins at least 7 days before PCI was significantly higher in the ST-E (-) group than in the ST-E (þ) group. It is necessary to administer statins to patients who are planned to undergo PCI earlier than 7 days. Furthermore, ST-segment elevation on IcECG after the procedure might be associated with 1-year MACE. The total of MI, repeat revascularization and hospitalization for heart failure affected 1-year MACE. We think that ST-segment elevation on post-IcECG might be a surrogate marker and patients with ST-segment elevation on post-IcECG might be 'vulnerable patients which might be prone to cardiac event'. Some studies demonstrated that intravenous nicorandil administration reduced cardiac biomarker elevation after elective PCI. 21 More constructive treatment should be needed to these high-risk patients with ST-segment elevation on IcECG after the procedure to reduce future cardiac events. Prospective studies will be advocated to investigate the propriety of FD-OCT-guided use of embolic protection devices and IcECG-guided administration of pharmacological agents to prevent and treat impaired microvascular perfusion during elective PCI.
Study limitations
Major limitation of this study is small sample size. Because of the invasive nature of this study, only 84 patients were included. In addition, this study was conducted in only a single institution in a nonrandomized, retrospective manner. Although all patients achieved final TIMI 3 flow grade in this study, the exclusion of patients with large vessel diameter may have led to all patients achieving final TIMI3 flow grade. Use of other measures, including myocardial blush grade, flow velocity by Doppler wire, microvascular obstruction by CMR and contrast deficit by contrast echocardiography, might have provided additional information on microvascular perfusion. Inability to measure plaque volume is one of the major limitations of FD-OCT. No patient received glycoprotein IIb/IIIa receptor inhibitor because they are not available in Japan. Plaque characteristics and stent status may affect the development of in-stent restenosis. However, only one patient had in-stent restenosis because all patients were treated by second or third generation drug-eluting stent and we excluded patients with reduced renal function, tortuous vessels or severe calcified lesions who are likely to develop in-stent restenosis. So, we could not evaluate predictive value for in-stent restenosis. We did not perform an analysis of the long-term prognostic value of STsegment elevation on IcECG.
Conclusions
Plaque features assessed by FD-OCT might be associated with impaired microvascular perfusion and ST-segment elevation on IcECG after the procedure could predict 1-year cardiac events after elective PCI. Further studies should be advocated to investigate the more clinical prognostic value of relation between plaque features at culprit lesions assessed by FD-OCT and IcECG for patients who underwent elective PCI and better therapeutic options to reduce cardiovascular event.
